In conclusion, the authors acknowledge the critical role of ALKBH5, FTO, and YTHDF2 in the RA’s pathogenesis and disclose these compounds as promising biomarkers for RA [158]. This evidence concerns the gene ALKBH5 and rheumatoid arthritis.